Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses or recommends any products or services. Consult your physician regarding any treatment or therapy.
We had the privilege of hosting a one-hour Q&A with Dr. Charles Rudin, Deputy Director of the Cancer Center at Memorial Sloan Kettering and one of the world’s leading experts in lung cancer research and care.
This “Ask the Expert” session focuses on small cell lung cancer (SCLC) while also addressing updates in non–small cell lung cancer (NSCLC). It’s a conversational, patient-friendly discussion with straight answers from one of the top voices in the field.
We cover:
- The difference between limited and extensive-stage SCLC
- Current standards of care, including chemo and immunotherapy combinations
- How recurrence is managed and what options exist after first-line treatment
- Emerging clinical trials and new research shaping the future of care
- What’s new in NSCLC and SCLC, including targeted and immune-based therapies
- And more
